Nextrials? Prism wins gold in the mobile star awards for health care data capture technology.
Nextrials’ Prism Wins Gold in the Mobile Star Awards for Healthcare Data Capture Technology
Prism selected as a top category winner in annual reader’s choice competition
San Ramon, CA – November 3, 2008
– Nextrials, Inc., a leader in clinical research software and services, today announced that its flagship electronic data capture and clinical trial management software, Prism®, captured a Gold Mobile Star Award™ from MobileVillage®, the 15-year leader in market development and news services about mobile technology. Prism was a winner in the enterprise software category for healthcare data capture.
Nextrials’ Prism is purpose-built for the pharmaceutical, medical device and biotechnology industries and melds sophisticated clinical trial management functionality with Electronic Data Capture (EDC) in a single, integrated package. It is currently used worldwide by pharmaceutical and biotechnology R&D teams developing novel treatments and therapeutics. Recently, Prism added support for remote access via the Apple® iPhone™, giving researchers anywhere/anytime access to ongoing clinical trial data.
“Despite the economic slowdown, recent studies have predicted minimal impact on the mobile and wireless industry,” said MobileVillage editor Gary Thayer. “People have fallen in love with mobile productivity and entertainment products, and there’s a real desire to discover and share the latest and greatest.”
The seventh annual Mobile Star Awards program honors the best companies, products, deployments and leaders in mobile and wireless technology. Winners are chosen by subscribers to Go Mobile®, MobileVillage’s free email newsletter for technology executives, mobile professionals, IT managers, developers and top tech journalists.
This year’s Mobile Star Awards winners are posted online at
http://www.mobilevillage.com/awards.htm
.
About MobileVillage®
Founded in 1993, MobileVillage is a market and solution development company dedicated to advancing mobile and wireless productivity in a wide range of industries. MobileVillage accomplishes this by fostering education and alliances through its Mobile "Best of Breed" solution identification, event partnerships, an online industry directory, industry job postings, daily online news, its widely respected Go Mobile® newsletter, a Mobile Mentors™ program, and popular annual Mobile Star Awards™ program. Visit MobileVillage online at www.mobilevillage.com <
http://www.mobilevillage.com
> .
About Nextrials, Inc.
Founded by pharmaceutical researchers in 1999, Nextrials offers today’s most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com <
http://www.nextrials.com
> or call 925-355-3000. A podcast by co-founder and CEO James Rogers on the incorporation of electronic health records into the clinical trial process is also available at
http://pharmavoice.com/podcasts
.
MobileVillage®, Go Mobile®, Mobile Star Awards™ and Mobile Mentors™ are trademarks or registered trademarks of MobileVillage / PDA Inc.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.